|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
70,932,000 |
Market
Cap: |
2.68(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$15.81 - $52.44 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on changing the paradigm for the treatment of rare genetic diseases of obesity, which are characterized by early-onset, severe obesity and hyperphagia, a pathological and insatiable hunger. Co. is developing IMCIVREE (setmelanotide) as a medicine strategy for a subset of individuals who have severe obesity due to genetic variants that impair the melanocortin-4 receptor pathway, a pathway in the brain that is responsible for regulating hunger, caloric intake and energy expenditure, which consequently affect body weight.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
164,376 |
307,851 |
390,685 |
429,469 |
Total Sell Value |
$6,457,019 |
$13,147,582 |
$15,609,906 |
$16,448,857 |
Total People Sold |
7 |
7 |
7 |
8 |
Total Sell Transactions |
10 |
32 |
42 |
61 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Chien Jennifer |
EVP, Head of North America |
|
2023-08-07 |
4 |
AS |
$24.18 |
$271,347 |
D/D |
(11,223) |
3,294 |
|
68% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-08-07 |
4 |
OE |
$6.80 |
$58,419 |
D/D |
8,591 |
14,517 |
|
- |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2023-07-26 |
4 |
AS |
$17.64 |
$16,405 |
D/D |
(930) |
8,418 |
|
92% |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2023-07-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
9,348 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-06-16 |
4 |
OE |
$6.88 |
$13,760 |
D/D |
2,000 |
61,406 |
|
- |
|
Mathers Edward T |
Director |
|
2023-03-02 |
4 |
A |
$0.00 |
$0 |
I/I |
5,771 |
5,771 |
|
- |
|
Mazabraud Yann |
EVP, Head of International |
|
2023-02-14 |
4 |
AS |
$27.03 |
$31,814 |
D/D |
(1,177) |
3,827 |
|
-36% |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-02-14 |
4 |
AS |
$26.87 |
$14,886 |
D/D |
(554) |
3,741 |
|
-36% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-02-14 |
4 |
AS |
$26.87 |
$17,062 |
D/D |
(635) |
4,940 |
|
-36% |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-02-14 |
4 |
AS |
$26.87 |
$18,863 |
D/D |
(702) |
59,406 |
|
-36% |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
4,295 |
|
- |
|
Mazabraud Yann |
EVP, Head of International |
|
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
5,004 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
5,575 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,344 |
60,108 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-02-09 |
4/A |
AS |
$27.51 |
$38,872 |
D/D |
(1,413) |
57,764 |
|
- |
|
Mazabraud Yann |
EVP, Head of International |
|
2023-02-09 |
4/A |
AS |
$27.51 |
$42,998 |
D/D |
(1,563) |
2,973 |
|
- |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2023-02-09 |
4/A |
AS |
$27.51 |
$23,191 |
D/D |
(843) |
6,142 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-02-09 |
4/A |
AS |
$27.51 |
$33,122 |
D/D |
(1,204) |
3,544 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-02-09 |
4/A |
AS |
$27.51 |
$25,612 |
D/D |
(931) |
2,732 |
|
- |
|
Roberts William T. |
Chief Accounting Officer |
|
2023-02-09 |
4/A |
AS |
$27.51 |
$26,657 |
D/D |
(969) |
6,284 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-02-09 |
4 |
AS |
$27.66 |
$32,971 |
D/D |
(1,192) |
3,556 |
|
-33% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,438 |
4,748 |
|
- |
|
Mazabraud Yann |
EVP, Head of International |
|
2023-02-09 |
4 |
AS |
$27.66 |
$42,818 |
D/D |
(1,548) |
2,988 |
|
-33% |
|
Mazabraud Yann |
EVP, Head of International |
|
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,438 |
4,536 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-02-09 |
4 |
AS |
$27.66 |
$25,475 |
D/D |
(921) |
2,742 |
|
-33% |
|
251 Records found
|
|
Page 4 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|